Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ferrara

Showing results (171-180 of 178) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 178 results.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 3, 2013
Peamaclein--a new peach allergenic protein: similarities, differences and misleading features compared to Pru p 3L Tuppo, C Alessandri, D Pomponi, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|January 21, 2019
Lessons learned from 227 biological meshes used for the surgical treatment of ventral abdominal defectsN Baldan, G Munegato, A Di Leo, et al.
Blood|February 25, 1999
Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemiaA M Carella, E Lerma, M T Corsetti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
Circulating innate immune markers and outcomes in treatment-naïve advanced non-small cell lung cancer patientsM Charrier, L Mezquita, B Lueza, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
Pre-dilution haemofiltration--the Sardinian multicentre studies: present and future. The Sardinian Collaborative Study Group on Haemofiltration On-LineP Altieri, G Sorba, P Bolasco, et al.
Lung Cancer (Amsterdam, Netherlands)|August 1, 2025
Definition of resectable stage III non-small cell lung cancer: A systematic review from EORTC lung cancer groupE Xenophontos, N Giaj Levra, V Durieux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2025
DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small-cell lung cancerB Ricciuti, S Scalera, X Wang, et al.
ESMO Open|December 1, 2022
PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkersG Lo Russo, F Sgambelluri, A Prelaj, et al.
Pageof 18

Showing results (171-180 of 178) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 178 results.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 3, 2013
Peamaclein--a new peach allergenic protein: similarities, differences and misleading features compared to Pru p 3L Tuppo, C Alessandri, D Pomponi, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|January 21, 2019
Lessons learned from 227 biological meshes used for the surgical treatment of ventral abdominal defectsN Baldan, G Munegato, A Di Leo, et al.
Blood|February 25, 1999
Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemiaA M Carella, E Lerma, M T Corsetti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
Circulating innate immune markers and outcomes in treatment-naïve advanced non-small cell lung cancer patientsM Charrier, L Mezquita, B Lueza, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
Pre-dilution haemofiltration--the Sardinian multicentre studies: present and future. The Sardinian Collaborative Study Group on Haemofiltration On-LineP Altieri, G Sorba, P Bolasco, et al.
Lung Cancer (Amsterdam, Netherlands)|August 1, 2025
Definition of resectable stage III non-small cell lung cancer: A systematic review from EORTC lung cancer groupE Xenophontos, N Giaj Levra, V Durieux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2025
DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small-cell lung cancerB Ricciuti, S Scalera, X Wang, et al.
ESMO Open|December 1, 2022
PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkersG Lo Russo, F Sgambelluri, A Prelaj, et al.
Pageof 18